Sodium Hydroxide → 3-{4-[(3,3-Dimethyl-cyclobutyl)-(3-methyl-quinolin-2-ylamino)-methyl]-benzoylamino}-propionic acid
Reaction equation
C[O:2][C:3](=[O:34])[CH2:4][CH2:5][NH:6][C:7](=[O:33])[C:8]1[CH:13]=[CH:12][C:11]([CH:14]([CH:27]2[CH2:30][C:29]([CH3:32])([CH3:31])[CH2:28]2)[NH:15][C:16]2[C:25]([CH3:26])=[CH:24][C:23]3[C:18](=[CH:19][CH:20]=[CH:21][CH:22]=3)[N:17]=2)=[CH:10][CH:9]=1.[OH-].[Na+]>CO.C1COCC1>[CH3:31][C:29]1([CH3:32])[CH2:30][CH:27]([CH:14]([NH:15][C:16]2[C:25]([CH3:26])=[CH:24][C:23]3[C:18](=[CH:19][CH:20]=[CH:21][CH:22]=3)[N:17]=2)[C:11]2[CH:12]=[CH:13][C:8]([C:7]([NH:6][CH2:5][CH2:4][C:3]([OH:34])=[O:2])=[O:33])=[CH:9][CH:10]=2)[CH2:28]1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
The title compound was prepared by treating 3-{4-[(3,3-dimethyl-cyclobutyl)-(3-methyl-quinolin-2-ylamino)-methyl]-benzoylamino}-propionic acid methyl ester, isomer 1 (intermediate 70) with 1N NaOH (2.5 eq.) in methanol/THF in a similar manner as described in Example 19 to provide the title compound. Analytical chiral SFC: (Chiralpak AD-H column, 4.6 mm×25 cm, 30% methanol/carbon dioxide eluent, 2.5 mL/min flow rate, 2.78 retention time); 1H NMR (400 MHz, CDCl3) δ 7.66 (d, J=8.4 Hz, 2H), 7.56-7.63 (m, 2H), 7.44-7.52 (m, 3H), 7.37-7.44 (m, 1H), 7.11-7.19 (m, 1H), 5.30 (d, J=9.8 Hz, 1H), 3.67 (q, J=5.9 Hz, 2H), 2.62-2.70 (m, 3H), 2.29 (s, 3H), 1.94 (ddd, J=11.2, 8.2, 3.0 Hz, 1H), 1.70-1.82 (m, 1H), 1.62-1.70 (m, 2H), 1.13 (s, 3H), 1.08 (s, 3H); MS (M+1): 446.4.
Workup
- customThe title compound was prepared
Sources & evidence
- ORD record
- ord-a2495c28cc6f4134a074c44f0f6f7f4d
- Source dataset
- uspto-grants-2015_01
- Patent number
- US08927577B2
Reaction notes
Loading…